HOUSE DOCKET, NO. 3037 FILED ON: 1/19/2023
HOUSE . . . . . . . . . . . . . . . No. 959
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Daniel Cahill
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act prohibiting discrimination against 340b drug discount program participants.
_______________
PETITION OF:
NAME: DISTRICT/ADDRESS: DATE ADDED:
Daniel Cahill 10th Essex 1/19/2023
Peter Capano 11th Essex 1/30/2023
Joanne M. Comerford Hampshire, Franklin and Worcester 1/30/2023
John J. Cronin Worcester and Middlesex 1/30/2023
David Henry Argosky LeBoeuf 17th Worcester 1/31/2023
Lindsay N. Sabadosa 1st Hampshire 1/31/2023
Andres X. Vargas 3rd Essex 1/31/2023
Jack Patrick Lewis 7th Middlesex 1/31/2023
Patricia A. Duffy 5th Hampden 2/1/2023
Frank A. Moran 17th Essex 2/3/2023
Thomas M. Stanley 9th Middlesex 2/3/2023
Tram T. Nguyen 18th Essex 2/3/2023
Rodney M. Elliott 16th Middlesex 2/3/2023
James J. O'Day 14th Worcester 2/7/2023
James K. Hawkins 2nd Bristol 2/13/2023
Vanna Howard 17th Middlesex 2/13/2023
Brian W. Murray 10th Worcester 2/17/2023
Estela A. Reyes 4th Essex 2/22/2023
1 of 2
Rebecca L. Rausch Norfolk, Worcester and Middlesex 2/24/2023
Rady Mom 18th Middlesex 3/24/2023
Tommy Vitolo 15th Norfolk 4/5/2023
Ryan M. Hamilton 15th Essex 6/14/2023
2 of 2
 HOUSE DOCKET, NO. 3037 FILED ON: 1/19/2023
HOUSE . . . . . . . . . . . . . . . No. 959
By Representative Cahill of Lynn, a petition (accompanied by bill, House, No. 959) of Daniel
Cahill and others for legislation to prohibit discrimination against 340B drug discount program
participants. Financial Services.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act prohibiting discrimination against 340b drug discount program participants.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Chapter 32A of the General laws, as appearing in the 2020 Official Edition,
2 is hereby amended by inserting after Section 33, the following new section:-
3 Section 34
4 (a) DEFINITIONS. For purposes of this section:
5 (1) “340B-covered entity” has the same meaning as that set forth in section 256b(a)(4) of
6 Title 42 of the United States Code.
7 (2) “Contract pharmacy” means a pharmacy operating under contract with a 340B-
8 covered entity to provide dispensing services to the 340B-covered entity as described in 75 Fed.
9 Reg. 10,272 (Mar. 5, 2010).
10 (3) “Drug coverage” means:
1 of 16
11 (i) An insurance company organized under this Chapter providing reimbursement for
12 covered outpatient drugs, excepting any Medicaid insurance plan of the Commonwealth as
13 defined in G. L. c. 118E or other applicable laws governing Medicaid in the Commonwealth;
14 (ii) Notwithstanding the foregoing, the term “drug coverage” does not include any
15 amounts paid by an individual on his or her own behalf or on behalf of another individual.
16 (b) TERMS OF AGREEMENTS. No drug coverage that reimburses a-340B-covered
17 entity or its contract pharmacy for drugs that are subject to an agreement under section
18 256b(a)(1) of Title 42 of the United States Code:
19 (i) Shall reimburse a covered entity or contract pharmacy for a quantity of a 340B drug in
20 an amount less than such plan, issuer, or manager would pay to any other similarly situated entity
21 or pharmacy that is not a covered entity or a contract pharmacy for such quantity of such drug on
22 the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or
23 pharmacy dispenses 340B drugs.
24 (ii) Shall discriminate against a 340B-covered entity (as defined in subsection (a)(1)) or a
25 contract pharmacy (as defined in subsection (a)(2)) by imposing requirements, exclusions,
26 reimbursement terms, or other conditions on such entity or pharmacy that differ from those
27 applied to entities or pharmacies that are not 340B-covered entities or contract pharmacies on the
28 basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or
29 pharmacy dispenses 340B drugs, including by taking any action prohibited under subsection (b).
30 (ii) Shall impose any terms or conditions on 340B-covered entities or contract
31 pharmacies with respect to any of the following that differ from such terms or conditions applied
32 to other similarly situated entities or pharmacies that are not 340B-covered entities or contract
2 of 16
33 pharmacies on the basis that the entity or pharmacy is a 340B-covered entity or contract
34 pharmacy or that the entity or pharmacy dispenses 340B drugs:
35 (A) Fees, chargebacks, clawbacks, adjustments, or other assessments.
36 (B) Professional dispensing fees.
37 (C) Restrictions or requirements regarding participation in standard or preferred
38 pharmacy networks.
39 (D) Requirements relating to the frequency or scope of audits or to inventory
40 management systems using generally accepted accounting principles.
41 (iii) Shall require a claim for a drug to include a modifier to indicate that the drug is a
42 340B drug, or any other method of identifying the claim as 340B, unless the claim is for
43 payment, directly or indirectly, by Medicaid as defined in Section 8 of Chapter 118E.
44 (c) Patient’s Choice. With respect to a patient eligible to receive drugs that are
45 subject to an agreement under section 256b of Title 42 of the United States Code from a 340B-
46 covered entity or its contract pharmacy, no entity that makes payment for such drugs shall
47 discriminate against the 340B-covered entity or its contract pharmacy in a manner that prevents,
48 steers, or otherwise interferes with the patient’s choice to receive such drugs from the 340B-
49 covered entity or its contract pharmacy.
50 SECTION 2. Chapter 175 of the General laws, as appearing in the 2020 Official Edition,
51 is hereby amended by inserting after Section 47tt, the following new section:-
52 Section 47uu
3 of 16
53 (a) DEFINITIONS. For purposes of this section:
54 (1) “340B-covered entity” has the same meaning as that set forth in section 256b(a)(4) of
55 Title 42 of the United States Code.
56 (2) “Contract pharmacy” means a pharmacy operating under contract with a 340B-
57 covered entity to provide dispensing services to the 340B-covered entity as described in 75 Fed.
58 Reg. 10,272 (Mar. 5, 2010).
59 (3) “Drug coverage” means:
60 (i) An insurance company organized under this Chapter providing reimbursement for
61 covered outpatient drugs, excepting any Medicaid insurance plan of the Commonwealth as
62 defined in G. L. c. 118E or other applicable laws governing Medicaid in the Commonwealth;
63 (ii) Notwithstanding the foregoing, the term “drug coverage” does not include any
64 amounts paid by an individual on his or her own behalf or on behalf of another individual.
65 (b) TERMS OF AGREEMENTS. No drug coverage that reimburses a-340B-covered
66 entity or its contract pharmacy for drugs that are subject to an agreement under section
67 256b(a)(1) of Title 42 of the United States Code:
68 (i) Shall reimburse a covered entity or contract pharmacy for a quantity of a 340B drug in
69 an amount less than such plan, issuer, or manager would pay to any other similarly situated entity
70 or pharmacy that is not a covered entity or a contract pharmacy for such quantity of such drug on
71 the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or
72 pharmacy dispenses 340B drugs.
4 of 16
73 (ii) Shall discriminate against a 340B-covered entity (as defined in subsection (a)(1)) or a
74 contract pharmacy (as defined in subsection (a)(2)) by imposing requirements, exclusions,
75 reimbursement terms, or other conditions on such entity or pharmacy that differ from those
76 applied to entities or pharmacies that are not 340B-covered entities or contract pharmacies on the
77 basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or
78 pharmacy dispenses 340B drugs, including by taking any action prohibited under subsection (b).
79 (ii) Shall impose any terms or conditions on 340B-covered entities or contract
80 pharmacies with respect to any of the following that differ from such terms or conditions applied
81 to other similarly situated entities or pharmacies that are not 340B-covered entities or contract
82 pharmacies on the basis that the entity or pharmacy is a 340B-covered entity or contract
83 pharmacy or that the entity or pharmacy dispenses 340B drugs:
84 (A) Fees, chargebacks, clawbacks, adjustments, or other assessments.
85 (B) Professional dispensing fees.
86 (C) Restrictions or requirements regarding participation in standard or preferred
87 pharmacy networks.
88 (D) Requirements relating to the frequency or scope of audits or to inventory
89 management systems using generally accepted accounting principles.
90 (iii) Shall require a claim for a drug to include a modifier to indicate that the drug is a
91 340B drug, or any other method of identifying the claim as 340B, unless the claim is for
92 payment, directly or indirectly, by Medicaid as defined in Section 8 of Chapter 118E.
5 of 16
 93 (c) Patient’s Choice. With respect to a patient eligible to receive drugs that are
94 subject to an agreement under section 256b of Title 42 of the United States Code from a 340B-
95 covered entity or its contract pharmacy, no entity that makes payment for such drugs shall
96 discriminate against the 340B-covered entity or its contract pharmacy in a manner that prevents,
97 steers, or otherwise interferes with the patient’s choice to receive such drugs from the 340B-
98 covered entity or its contract pharmacy.
99 SECTION 3. Chapter 176A of the General laws, as appearing in the 2020 Official
100 Edition, is hereby amended by inserting after Section 39, the following Section:
101 Section 40
102 (a) DEFINITIONS. For purposes of this section:
103 (1) “340B-covered entity” has the same meaning as that set forth in section 256b(a)(4) of
104 Title 42 of the United States Code.
105 (2) “Contract pharmacy” means a pharmacy operating under contract with a 340B-
106 covered entity to provide dispensing services to the 340B-covered entity as described in 75 Fed.
107 Reg. 10,272 (Mar. 5, 2010).
108 (3) “Drug coverage” means:
109 (i) An insurance company organized under this Chapter providing reimbursement for
110 covered outpatient drugs, excepting any Medicaid insurance plan of the Commonwealth as
111 defined in G. L. c. 118E or other applicable laws governing Medicaid in the Commonwealth;
112 (ii) Notwithstanding the foregoing, the term “drug coverage” does not include any
113 amounts paid by an individual on his or her own behalf or on behalf of another individual.
6 of 16
114 (b) TERMS OF AGREEMENTS. No drug coverage that reimburses a-340B-covered
115 entity or its contract pharmacy for drugs that are subject to an agreement under section
116 256b(a)(1) of Title 42 of the United States Code:
117 (i) Shall reimburse a covered entity or contract pharmacy for a quantity of a 340B drug in
118 an amount less than such plan, issuer, or manager would pay to any other similarly situated entity
119 or pharmacy that is not a covered entity or a contract pharmacy for such quantity of such drug on
120 the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or
121 pharmacy dispenses 340B drugs.
122 (ii) Shall discriminate against a 340B-covered entity (as defined in subsection (a)(1)) or a
123 contract pharmacy (as defined in subsection (a)(2)) by imposing requirements, exclusions,
124 reimbursement terms, or other conditions on such entity or pharmacy that differ from those
125 applied to entities or pharmacies that are not 340B-covered entities or contract pharmacies on the
126 basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or
127 pharmacy dispenses 340B drugs, including by taking any action prohibited under subsection (b).
128 (ii) Shall impose any terms or conditions on 340B-covered entities or contract
129 pharmacies with respect to any of the following that differ from such terms or conditions applied
130 to other similarly situated entities or pharmacies that are not 340B-covered entities or contract
131 pharmacies on the basis that the entity or pharmacy is a 340B-covered entity or contract
132 pharmacy or that the entity or pharmacy dispenses 340B drugs:
133 (A) Fees, chargebacks, clawbacks, adjustments, or other assessments.
134 (B) Professional dispensing fees.
7 of 16
135 (C) Restrictions or requirements regarding participation in standard or preferred
136 pharmacy networks.
137 (D) Requirements relating to the frequency or scope of audits or to inventory
138 management systems using generally accepted accounting principles.
139 (iii) Shall require a claim for a drug to include a modifier to indicate that the drug is a
140 340B drug, or any other method of identifying the claim as 340B, unless the claim is for
141 payment, directly or indirectly, by Medicaid as defined in Section 8 of Chapter 118E.
142 (c) Patient’s Choice. With respect to a patient eligible to receive drugs that are
143 subject to an agreement under section 256b of Title 42 of the United States Code from a 340B-
144 covered entity or its contract pharmacy, no entity that makes payment for such drugs shall
145 discriminate against the 340B-covered entity or its contract pharmacy in a manner that prevents,
146 steers, or otherwise interferes with the patient’s choice to receive such drugs from the 340B-
147 covered entity or its contract pharmacy.
148 SECTION 4. Section 1 of Chapter 176B of the General laws, as appearing in the 2020
149 Official Edition, is hereby amended by inserting after the definition of “Commissioner”, the
150 following new definitions:
151 “340B-covered entity” has the same meaning as that set forth in section 256b(a)(4) of
152 Title 42 of the United States Code.
153 “Contract pharmacy” means a pharmacy operating under contract with a 340B-covered
154 entity to provide dispensing services to the 340B-covered entity as described in 75 Fed. Reg.
155 10,272 (Mar. 5, 2010).
8 of 16
156 “Drug coverage” means:
157 (i) An insurance company organized under this Chapter providing reimbursement for
158 covered outpatient drugs, excepting any Medicaid insurance plan of the Commonwealth as
159 defined in G. L. c. 118E or other applicable laws governing Medicaid in the Commonwealth;
160 (ii) Notwithstanding the foregoing, the term “drug coverage” does not include any
161 amounts paid by an individual on his or her own behalf or on behalf of another individual.
162 SECTION 5. Chapter 176B of the General laws, as appearing in the 2020 Official
163 Edition, is hereby further amended by inserting after Section 26 the following new section:-
164 Section 27.
165 (a) TERMS OF AGREEMENTS. No drug coverage that reimburses a-340B-covered
166 entity or its cont